166 related articles for article (PubMed ID: 9357789)
21. Heme arginate therapy enhanced adiponectin and atrial natriuretic peptide, but abated endothelin-1 with attenuation of kidney histopathological lesions in mineralocorticoid-induced hypertension.
Ndisang JF; Jadhav A
J Pharmacol Exp Ther; 2010 Jul; 334(1):87-98. PubMed ID: 20392817
[TBL] [Abstract][Full Text] [Related]
22. Regulation of aortic atrial natriuretic factor and angiotensinogen in experimental hypertension.
Ogawa T; Linz W; Schölkens BA; de Bold AJ
J Cardiovasc Pharmacol; 1998 Dec; 32(6):1001-8. PubMed ID: 9869508
[TBL] [Abstract][Full Text] [Related]
23. Enhanced expression of the endothelin-1 gene in blood vessels of DOCA-salt hypertensive rats: correlation with vascular structure.
Schiffrin EL; Larivière R; Li JS; Sventek P
J Vasc Res; 1996; 33(3):235-48. PubMed ID: 8924521
[TBL] [Abstract][Full Text] [Related]
24. Dietary salt supplementation selectively downregulates NPR-C receptor expression in kidney independently of ANP.
Sun JZ; Chen SJ; Majid-Hasan E; Oparil S; Chen YF
Am J Physiol Renal Physiol; 2002 Feb; 282(2):F220-7. PubMed ID: 11788435
[TBL] [Abstract][Full Text] [Related]
25. Role of natriuretic peptide receptor type C in Dahl salt-sensitive hypertensive rats.
Nagase M; Ando K; Katafuchi T; Kato A; Hirose S; Fujita T
Hypertension; 1997 Aug; 30(2 Pt 1):177-83. PubMed ID: 9260977
[TBL] [Abstract][Full Text] [Related]
26. Variable renal atrial natriuretic factor gene expression in hypertension.
Ogawa T; Linz W; Schölkens BA; de Bold AJ
Hypertension; 1999 Jun; 33(6):1342-7. PubMed ID: 10373213
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of C-type natriuretic peptide receptor by vasonatrin peptide in cardiac myocytes and fibroblasts.
Lü SY; Zhu MZ; Wang DS; Yu J; Guo HT; Hu YZ; Wei QM
Acta Pharmacol Sin; 2004 Apr; 25(4):424-30. PubMed ID: 15066207
[TBL] [Abstract][Full Text] [Related]
28. Gestational hypertension in atrial natriuretic peptide knockout mice and the developmental origins of salt-sensitivity and cardiac hypertrophy.
Armstrong DW; Tse MY; O'Tierney-Ginn PF; Wong PG; Ventura NM; Janzen-Pang JJ; Matangi MF; Johri AM; Croy BA; Adams MA; Pang SC
Regul Pept; 2013 Sep; 186():108-15. PubMed ID: 23981445
[TBL] [Abstract][Full Text] [Related]
29. B-type natriuretic peptide receptor expression and activity are hormonally regulated in rat ovarian cells.
Noubani A; Farookhi R; Gutkowska J
Endocrinology; 2000 Feb; 141(2):551-9. PubMed ID: 10650935
[TBL] [Abstract][Full Text] [Related]
30. Xanthine oxidase and mitochondria contribute to vascular superoxide anion generation in DOCA-salt hypertensive rats.
Viel EC; Benkirane K; Javeshghani D; Touyz RM; Schiffrin EL
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H281-8. PubMed ID: 18487445
[TBL] [Abstract][Full Text] [Related]
31. Altered regulation of renal nitric oxide and atrial natriuretic peptide systems in angiotensin II-induced hypertension.
Bae EH; Ma SK; Lee J; Kim SW
Regul Pept; 2011 Oct; 170(1-3):31-7. PubMed ID: 21616096
[TBL] [Abstract][Full Text] [Related]
32. Osmoregulation of natriuretic peptide receptors in bromoethylamine-treated rat kidney.
Yuan K; Jin X; Gao S; Shah A; Kim SY; Kim SZ; Kim SH
Peptides; 2009 Jun; 30(6):1137-43. PubMed ID: 19463747
[TBL] [Abstract][Full Text] [Related]
33. Renal actions of atrial natriuretic peptide in spontaneously hypertensive rats: the role of nitric oxide as a key mediator.
Elesgaray R; Caniffi C; Savignano L; Romero M; Mac Laughlin M; Arranz C; Costa MA
Am J Physiol Renal Physiol; 2012 Jun; 302(11):F1385-94. PubMed ID: 22378819
[TBL] [Abstract][Full Text] [Related]
34. Reduced NOS3 phosphorylation mediates reduced NO/cGMP signaling in mesenteric arteries of deoxycorticosterone acetate-salt hypertensive rats.
Sasser JM; Sullivan JC; Elmarakby AA; Kemp BE; Pollock DM; Pollock JS
Hypertension; 2004 May; 43(5):1080-5. PubMed ID: 14993198
[TBL] [Abstract][Full Text] [Related]
35. Effects of brain mineralocorticoid receptor blockade on blood pressure and renal functions in DOCA-salt hypertension.
Rahmouni K; Sibug RM; De Kloet ER; Barthelmebs M; Grima M; Imbs JL; De Jong W
Eur J Pharmacol; 2002 Feb; 436(3):207-16. PubMed ID: 11858800
[TBL] [Abstract][Full Text] [Related]
36. C-atrial natriuretic peptide (ANP)
Lu YY; Li SJ; Zhang Z; He S; Guo YT; Hong MN; Shao S; Wang RQ; Zhang J; Wang JG; Gao PJ; Li XD
Exp Cell Res; 2023 Oct; 431(1):113738. PubMed ID: 37572787
[TBL] [Abstract][Full Text] [Related]
37. Heme-arginate suppresses phospholipase C and oxidative stress in the mesenteric arterioles of mineralcorticoid-induced hypertensive rats.
Ndisang JF; Jadhav A
Hypertens Res; 2010 Apr; 33(4):338-47. PubMed ID: 20203687
[TBL] [Abstract][Full Text] [Related]
38. Natriuretic peptide gene expression in DOCA-salt hypertension after blockade of type B endothelin receptor.
Bianciotti LG; de Bold AJ
Am J Physiol Heart Circ Physiol; 2002 Mar; 282(3):H1127-34. PubMed ID: 11834512
[TBL] [Abstract][Full Text] [Related]
39. The 5-hydroxytryptamine2B receptor and 5-HT receptor signal transduction in mesenteric arteries from deoxycorticosterone acetate-salt hypertensive rats.
Watts SW; Baez M; Webb RC
J Pharmacol Exp Ther; 1996 May; 277(2):1103-13. PubMed ID: 8627522
[TBL] [Abstract][Full Text] [Related]
40. Blood pressure and renal responses to synthetic rat atrial natriuretic factor in deoxycorticosterone acetate-salt hypertension.
Kohzuki M; Abe K; Yasujima M; Kasai Y; Hiwatari M; Kanazawa M; Sato M; Omata K; Kudo K; Takeuchi K
Tohoku J Exp Med; 1989 Apr; 157(4):301-11. PubMed ID: 2525826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
